Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

NCT00335660 is registered in ClinicalTrials.gov with Avera Pharmaceuticals as lead sponsor.

NCT NCT00335660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
Lead sponsor
Avera Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2006
Completion date
September 30, 2007
Enrollment
62 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder syndrome